急性冠状动脉综合征抗血小板药物抵抗的研究进展及联合用药的安全性探讨
被引量:1
摘要
急性冠状动脉综合征(Acute coronary syn—drome,ACS)是由于动脉粥样硬化的不稳定斑块破裂,血小板在破裂的斑块表面黏附、激活、释放相关因子并聚集,同时激活凝血瀑布,导致冠状动脉内血栓形成,使冠状动脉部分或完全闭塞,出现心肌缺血或心肌梗死症状而产生的一组临床综合征。
出处
《医学理论与实践》
2013年第20期2686-2688,共3页
The Journal of Medical Theory and Practice
参考文献14
-
1郝恒剑,胡少东,许骥.急性心肌梗死直接介入治疗后无复流现象形成因素分析[J].心肺血管病杂志,2009,28(1):32-35. 被引量:9
-
2周玉杰,闫振娴.经皮冠状动脉介入治疗围手术期抗凝新视点[J].心肺血管病杂志,2008,27(1):52-54. 被引量:10
-
3Rajan L, Molitemo DJ. Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS? J]. Curr Cardiol Rep, 2011,13 : 303-311.
-
4汪国忠,白净,杨兴胜,顾菲菲,吕树铮.冠心病的早期发现与诊断[J].心肺血管病杂志,2010,29(4):344-348. 被引量:9
-
5Gurbel PA, Tantry US. Aspirin and clopidogrel resistance., con- sideration and Management J]. J Interv Cardiol, 2006, 19 (5) : 439-448.
-
6Hayward CP. Moffat KA,Spitzer E, et al. Results of an exter- nal proficiency testing exercise on platelet dense-granule defi- ciency testing by whole mount electron microscopy J]. Am J Clin Pathol, 2009,131 (5) : 671-675.
-
7Snoep JD, Hovens MM, Eikenboom JC, et al. Association of la- boratory-defined aspirin resistance with a higher risk of recur- rent cardiovascular events: a systematic review and meta-anal- ysisf_J. Arch Intern Med, 2007,167(15):1593-1599.
-
8Maeehi L, Christiaens L, Brabant S, et al. Resistance in vitro to Iow-dose aspirin is associated with platelet PIA1 (GPI]] a )poly- morphism but not wiII CS07T(GP la/lla)and C-5TKozak(GPI- baIpha) polymorphisms ]. J Am Coil Cardiol, 2003,42 (6) : 1115-1119.
-
9Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? [J]. Am Heart J, 2004,147 (2) : 293-300.
-
10Cox D, Maree AO, Dooley M, et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volun- teersf.J. Stroke, 2006,37 (8) : 2153-2158.
二级参考文献86
-
1韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量:53
-
2Tanaka A,Kawarahayashi T,Nishibori Y,et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction.Circulation,2002,105:2148-2152.
-
3Brosh D,Assali AR,Maser A,et al.Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.Am J Cardiol 2007,99:442-445.
-
4Singh M,Mathew V,Garratt KN,et al.Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic.Am J Med,2000,108:187-192.
-
5Kirma C,Izgi A,Dundar C,et al.Clinical and Procedural Predictors of No-Reilow Phenomenon After Primary Percutaneous Coronary Interventions.Ciro J,2008,72:716-721.
-
6Isaaz K,Robin C,Cerisier A,et al.A new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention.Coron Artery Dis,2006,17:261-269.
-
7De Luca G,Ernst N,Zijlstra F,et al.Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.J Am Coll Cardiol,2004,43:1363-1367.
-
8Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes.Circulation,2003,107:1497-1501.
-
9Zeymer U,Zahn R,Schiele R,et al.Early eptifibatide improves TIMI 3 pateacy before primary percutaneous coronary intervention for acute ST elevation myocardial infarction:Results of the randomized integtilin in acute myocardial infarction(INTAMI)pilot trial.Eur Heart J,2005,26:1971-1977.
-
10Iwakura K,Ito H,Nishikawa N,et al.Early temporal changes in coronary flow velocity pattern in patients with acute myocardial infarction demonstrating "no-reflow"phenomenon.Am J Cardiol,1999,84:415-419.
共引文献29
-
1路璐,武刚.急诊介入治疗急性心肌梗死时无复流现象的相关因素分析[J].黑龙江医学,2013,37(9):787-788.
-
2伍贵富,杜志民,胡承恒.经皮冠状动脉介入围手术期的抗凝与抗血小板治疗策略[J].新医学,2008,39(10):683-685. 被引量:10
-
3陈秀清,方建梅,邱寿珠.急性心肌梗死急诊介入治疗程序化管理体会[J].护理与康复,2010,9(6):534-535.
-
4黄瑛.氯吡格雷抵抗的研究现状[J].中国循证心血管医学杂志,2011,3(4):311-312. 被引量:6
-
5杜文伟,范印文,锦兰,贺宙斌,吴敬敬,张璇,李永强,燕建锋.新疆伊犁地区维吾尔族、锡伯族、汉族冠心病患者冠状动脉病变对比分析[J].心肺血管病杂志,2011,30(6):484-486. 被引量:1
-
6柳景华,吕昀,吕媛.对急性冠状动脉综合征抗血小板治疗的药物优化研究[J].心肺血管病杂志,2011,30(6):558-560. 被引量:5
-
7岑梅珠,刘凯东.35例急性前壁心肌梗死合并完全性右束支传导阻滞临床预后分析[J].心肺血管病杂志,2012,31(1):71-73. 被引量:16
-
8陈青,米树华,戴文龙,吴学思.经皮冠状动脉腔内介入围术期应用高维持剂量氯吡格雷对炎症因子的影响[J].心肺血管病杂志,2012,31(3):249-251. 被引量:2
-
9黄觊,钱海燕,李志忠,张京梅,程宇彤,王茜,陶英.国产比伐卢定对急性冠状动脉综合征患者介入术中凝血功能的影响[J].心肺血管病杂志,2012,31(5):545-547. 被引量:7
-
10王永梅,李宇,张兆琪,范占明,吕飙.高浓度对比剂在冠状动脉多排螺旋CT的应用[J].心肺血管病杂志,2012,31(5):596-599. 被引量:2
同被引文献14
-
1范岚,张伟,周宏灏.抗血小板药物的遗传药理学研究进展[J].中国药理学通报,2010,26(4):421-424. 被引量:14
-
2吴雅凝,赵娣,李宁,陈西敬.二磷酸腺苷受体拮抗剂类抗血小板药物研究进展[J].中国临床药理学与治疗学,2010,15(12):1434-1440. 被引量:9
-
3刘兴华(综述,徐亚伟(审校).质子泵抑制剂联用抗血小板药物研究进展[J].中国实用内科杂志,2011,31(7):549-550. 被引量:6
-
4王小东,张代富.血小板功能及抗血小板药物疗效检测的研究进展[J].同济大学学报(医学版),2011,32(4):120-124. 被引量:10
-
5卜晓斐,刘鹏,付晓丽,徐为人.噻吩并吡啶类抗血小板聚集药物研究概况[J].现代药物与临床,2012,27(1):43-48. 被引量:10
-
6谢媛,马向华.抗血小板药物抵抗的研究进展[J].医学综述,2012,18(20):3364-3367. 被引量:5
-
7李慕鹏,熊艳,陈小平.抗血小板药物替格瑞洛药代药效动力学及遗传药理学研究进展[J].中国临床药理学与治疗学,2014,19(2):214-222. 被引量:50
-
8赵梦华,石建平,李廷贵.围术期抗血小板药物临床应用管理的研究进展[J].河北医药,2014,36(8):1220-1222. 被引量:2
-
9黄玲芳,张二云,高波,吴晓俊,王峥涛.血小板信号转导及相关抗血小板药物的研究进展[J].中药新药与临床药理,2014,25(3):378-383. 被引量:8
-
10乔文豪,王秀,王佳丽,夏泉.抗血小板药物药理作用和临床应用的研究进展[J].安徽医药,2014,18(9):1621-1625. 被引量:12
-
1郭莞莹,舒可,朱榆红.阿司匹林与氯吡格雷在缺血性卒中患者治疗中的应用[J].临床医药实践,2014,23(8):603-605. 被引量:1
-
2季汉华,陈娜.血栓弹力图监测糖尿病患者经皮冠状动脉介入术后抗血小板药物抵抗的发生率[J].中华临床医师杂志(电子版),2012,6(16):4848-4850. 被引量:9
-
3冷利华,黄文胜,裴宜斌,何小伍.支架内血栓形成的原因及防治[J].转化医学杂志,2015,4(6):335-337. 被引量:2
-
4胡福莉,王天红,刘美霞,袁华兵,倪艳辉,曹广运,张清芬,袁静,许玉芳,王文静.抗血小板药物抵抗致冠状动脉支架植入术后亚急性血栓2例并文献复习[J].临床荟萃,2015,30(12):1352-1355. 被引量:1
-
5陈娜,季汉华.急性冠状动脉综合征伴慢性肾脏病患者介入术后抗血小板药物抵抗研究[J].临床心血管病杂志,2012,28(10):750-754. 被引量:4
-
6陈娜,季汉华.急性冠状动脉综合征患者介入术后抗血小板药物抵抗的临床研究[J].临床荟萃,2012,27(8):667-671. 被引量:4
-
7谢媛,马向华.抗血小板药物抵抗的研究进展[J].医学综述,2012,18(20):3364-3367. 被引量:5
-
8韩莹,冯力,李明星,胡永毅,冯涛.替格瑞洛对冠心病血小板药物抵抗患者的治疗作用[J].中国老年学杂志,2014,34(9):2393-2394. 被引量:13
-
9王薇,李勇.血栓弹力图监测不稳定性心绞痛合并阻塞性睡眠呼吸暂停综合征患者抗血小板药物的反应性[J].中国医药导报,2014,11(5):44-46. 被引量:6
-
10廖达平.强化抗栓治疗在对抗血小板药物抵抗的冠心病PCI术后伴有房颤患者中的应用[J].中国卫生产业,2011,8(06Z):62-62.